These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 18801902)
41. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist. Frändberg PA; Doufexis M; Kapas S; Chhajlani V Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737 [TBL] [Abstract][Full Text] [Related]
42. Pleiotropic functions of the transmembrane domain 6 of human melanocortin-4 receptor. Huang H; Tao YX J Mol Endocrinol; 2012 Dec; 49(3):237-48. PubMed ID: 23014839 [TBL] [Abstract][Full Text] [Related]
43. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Tao YX; Segaloff DL Endocrinology; 2003 Oct; 144(10):4544-51. PubMed ID: 12959994 [TBL] [Abstract][Full Text] [Related]
44. A heterozygous mutation in the third transmembrane domain causes a dominant-negative effect on signalling capability of the MC4R. Tarnow P; Rediger A; Brumm H; Ambrugger P; Rettenbacher E; Widhalm K; Hinney A; Kleinau G; Schaefer M; Hebebrand J; Krause G; Grüters A; Biebermann H Obes Facts; 2008; 1(3):155-62. PubMed ID: 20054175 [TBL] [Abstract][Full Text] [Related]
45. Role of third intracellular loop of the melanocortin 4 receptor in the regulation of constitutive activity. Kim DH; Shin SW; Baik JH Biochem Biophys Res Commun; 2008 Jan; 365(3):439-45. PubMed ID: 17986382 [TBL] [Abstract][Full Text] [Related]
47. Differential regulation of cAMP-mediated gene transcription and ligand selectivity by MC3R and MC4R melanocortin receptors. Lee EJ; Lee SH; Jung JW; Lee W; Kim BJ; Park KW; Lim SK; Yoon CJ; Baik JH Eur J Biochem; 2001 Feb; 268(3):582-91. PubMed ID: 11168397 [TBL] [Abstract][Full Text] [Related]
48. Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway. Wangensteen T; Kolsgaard ML; Mattingsdal M; Joner G; Tonstad S; Undlien D; Retterstol L Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):266-73. PubMed ID: 19301229 [TBL] [Abstract][Full Text] [Related]
49. MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels. Rodríguez Rondón AV; Welling MS; van den Akker ELT; van Rossum EFC; Boon EMJ; van Haelst MM; Delhanty PJD; Visser JA J Clin Endocrinol Metab; 2024 Sep; 109(10):2452-2466. PubMed ID: 38567654 [TBL] [Abstract][Full Text] [Related]
50. Functional and phylogenetic analyses of a melanocortin-4 receptor mutation in domestic pigs. Kim KS; Reecy JM; Hsu WH; Anderson LL; Rothschild MF Domest Anim Endocrinol; 2004 Jan; 26(1):75-86. PubMed ID: 14732454 [TBL] [Abstract][Full Text] [Related]
51. Mahoganoid and mahogany mutations rectify the obesity of the yellow mouse by effects on endosomal traffic of MC4R protein. Overton JD; Leibel RL J Biol Chem; 2011 May; 286(21):18914-29. PubMed ID: 21460229 [TBL] [Abstract][Full Text] [Related]
52. Molecular Analysis and Conformational Dynamics of Human MC4R Disease-Causing Mutations. Fatima MT; Islam Z; Kolatkar PR; Al-Shabeeb Akil AS Molecules; 2022 Jun; 27(13):. PubMed ID: 35807283 [TBL] [Abstract][Full Text] [Related]
53. A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population. Ochoa MC; Azcona C; Biebermann H; Brumm H; Razquin C; Wermter AK; Martínez JA; Hebebrand J; Hinney A; Moreno-Aliaga MJ; Marti A; Patiño A; Chueca M; Oyarzabal M; Pelach R; Clin Endocrinol (Oxf); 2007 May; 66(5):652-8. PubMed ID: 17492953 [TBL] [Abstract][Full Text] [Related]
54. Evolutionary aspects in evaluating mutations in the melanocortin 4 receptor. Stäubert C; Tarnow P; Brumm H; Pitra C; Gudermann T; Grüters A; Schöneberg T; Biebermann H; Römpler H Endocrinology; 2007 Oct; 148(10):4642-8. PubMed ID: 17628007 [TBL] [Abstract][Full Text] [Related]
55. Deletion of codons 88-92 of the melanocortin-4 receptor gene: a novel deleterious mutation in an obese female. Donohoue PA; Tao YX; Collins M; Yeo GS; O'Rahilly S; Segaloff DL J Clin Endocrinol Metab; 2003 Dec; 88(12):5841-5. PubMed ID: 14671178 [TBL] [Abstract][Full Text] [Related]
56. Functional characterization of a new human melanocortin-4 receptor homozygous mutation (N72K) that is associated with early-onset obesity. Delhanty PJ; Bouw E; Huisman M; Vervenne RM; Themmen AP; van der Lely AJ; van den Akker EL Mol Biol Rep; 2014 Dec; 41(12):7967-72. PubMed ID: 25163632 [TBL] [Abstract][Full Text] [Related]
57. Exposure of MC4R to agonist in the endoplasmic reticulum stabilizes an active conformation of the receptor that does not desensitize. Granell S; Molden BM; Baldini G Proc Natl Acad Sci U S A; 2013 Dec; 110(49):E4733-42. PubMed ID: 24248383 [TBL] [Abstract][Full Text] [Related]
58. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. Larsen LH; Echwald SM; Sørensen TI; Andersen T; Wulff BS; Pedersen O J Clin Endocrinol Metab; 2005 Jan; 90(1):219-24. PubMed ID: 15486053 [TBL] [Abstract][Full Text] [Related]
59. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Tao YX Endocr Rev; 2010 Aug; 31(4):506-43. PubMed ID: 20190196 [TBL] [Abstract][Full Text] [Related]
60. Pharmacological chaperones for the misfolded melanocortin-4 receptor associated with human obesity. Huang H; Wang W; Tao YX Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt A):2496-2507. PubMed ID: 28284973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]